Pathogenic amino acid substitutions in terms of missense variants count for up to <1% of dystrophinopathies [17] and can lead to either DMD or BMD [46] based on their pathogenic impact of the DMD protein structure and stability. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.